Europe Gastric Cancer Diagnostics Market is estimated to witness surging demand at a CAGR of 6.9% by 2028
Europe Gastric Cancer Diagnostics Market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.9% in the forecast period of 2021 to 2028 and is expected to reach USD 371.76 million by 2028 from USD 228.01 million in 2020.
Industry Analysis
The rising incidence of diabetes and growth of novel
technological advancements for Gastric cancer diagnostics assay are likely to
be the major drivers which propel the demand of the market in the forecast period.
Stomach cancer is a type of cancer that starts in the stomach and spreads
throughout the body. The stomach is a muscular pouch that lies immediately
below your ribs in the upper part of your abdomen. Your stomach takes in and
holds the food you eat before breaking it down and digesting it. Stomach
cancer, commonly referred to as gastric cancer, can occur in any section of the
stomach. Stomach cancers develop in the major section of the stomach in most
parts of the world (stomach body). Various diagnostic tests used for diagnosis
of cancer include prescreening tests, biopsy, biomarkers, imaging tests, PET/CT
scan and ultrasound among others.
Increase in incidence of gastrointestinal tumors,
lymphoma, and adenocarcinoma, Rise in alcohol consumptions and surge in
smoking, increase in the geriatric population, strategic initiatives by key
market players, recent advances in gastric cancer diagnostics is driving the
market growth. However, high cost of testing and lack of sufficient financial
support from health insurance policies is hampering the market growth. On the
contrary, rising healthcare expenditure, adoption of automated systems,
increased research and development on cancer diagnostics. Furthermore,
stringent regulations and policies for approving the complicated nature of
radiation devices and limitations of radiation tests.
The gastric cancer diagnostics market report provides
details of market share, new developments, and product pipeline analysis,
impact of domestic and localised market players, analyses opportunities in
terms of emerging revenue pockets, changes in market regulations, product
approvals, strategic decisions, product launches, geographic expansions, and
technological innovations in the market. To understand the analysis and the
gastric cancer diagnostics market scenario contact Data Bridge Market Research
for an Analyst Brief, our team will help you create a revenue impact solution
to achieve your desired goal.
Europe
Gastric Cancer Diagnostics Market Scope and Market Size
The Europe Gastric Cancer Diagnostics Market is
segmented on the based on the product type, diagnostics type, age group,
disease type, stage, gender, sample type, end user and distribution channel.
The growth among segments helps you analyse niche pockets of growth and
strategies to approach the market and determine your core application areas and
the difference in your target markets.
On the
basis of product type, the Europe Gastric Cancer Diagnostics Market is
segmented into
·
Instruments,
·
Reagents & consumables,
·
Services.
On the
basis of diagnostics type, the Europe Gastric Cancer
Diagnostics Market is segmented into
·
Gastric (pre) cancer screening
tests/physical exam
·
Confirmatory tests.
On the
basis of age group, the Europe Gastric Cancer Diagnostics Market is segmented
into
·
Adult,
·
Pediatric
·
Geriatrics.
On the
basis of type, the Europe Gastric Cancer Diagnostics Market is segmented
into
·
Intestinal or diffuse
adenocarcinoma,
·
Carcinoid tumor,
·
Gastrointestinal stromal tumor
[gist],
·
Gastric lymphoma
·
Others.
On the
basis of stage, the Europe Gastric Cancer Diagnostics Market is segmented into
·
Stage 0,
·
Stage I,
·
Stage II,
·
Stage III
·
Stage IV.
On the
basis of gender, the Europe Gastric Cancer Diagnostics Market is segmented into
·
Male
·
Female.
On the
basis of sample type, the Europe Gastric Cancer Diagnostics Market is segmented
into
·
Blood,
·
Tissue,
·
Urine,
·
Stool.
On the
basis of end users, the Europe Gastric Cancer Diagnostics Market is segmented
into
·
Diagnostic laboratories,
·
Hospitals,
·
Cancer research institutes,
·
Oncology specialty clinics
·
Others.
On the
basis of distribution channel, the Europe Gastric Cancer Diagnostics Market is
segmented into
·
Direct tender
·
Retail sales.
Grab a sample copy of the report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-gastric-cancer-diagnostics-market
Gastric
Cancer Diagnostics Market Country Level Analysis
The gastric cancer diagnostics market is analysed and
market size information is provided by the country, product type, diagnostics
type, age group, stage, gender, sample type, end user and distribution channel
as referenced above.
The
countries covered in the gastric cancer diagnostics Market report are the
·
Germany,
·
France,
·
Spain,
·
Italy,
·
Netherlands,
·
Switzerland,
·
Russia,
·
Belgium,
·
Turkey,
·
Ireland,
·
Rest of Europe.
Europe is expected to grow with the highest CAGR in
the forecasted periods as in the Europe’s Countries demand for gastric cancer
diagnostics product is increasing very rapidly with the urbanization due to
increase in prevalence across the globe. Germany is expected to dominate and
fastest in the market in the Europe market.
Competitive
Landscape and Europe Gastric Cancer Diagnostics Market Share Analysis
Europe Gastric Cancer Diagnostics Market
competitive landscape provides details by competitor. Details included are
company overview, company financials, revenue generated, market potential,
investment in research and development, new market initiatives, production
sites and facilities, company strengths and weaknesses, product launch, product
trials pipelines, product approvals, patents, product width and breadth,
application dominance, technology lifeline curve. The above data points
provided are only related to the company’s focus related to gastric cancer
diagnostics market.
The major
companies which are dealing in the gastric cancer diagnostics are
·
Biomérieux SA ,
·
Myriad Genetics, Inc.,
·
F. Hoffmann-La Roche Ltd,
·
GENERAL ELECTRIC COMPANY,
·
Agilent Technologies, Inc.,
·
Endofotonics Pte Ltd,
·
Biohit Oyj,
·
BIOCEPT, INC.,
·
FOUNDATION MEDICINE, INC.,
·
Diasorin S.p.A,
·
Paragon Genomics, Inc. And QIAGEN,
·
ACON Laboratories, Inc.,
·
Teco Diagnostics.,
·
Vela Diagnostics ,
·
Abbott, advacare Pharma,
·
Mirxes,
·
Fujirebio ( An H.U. Group company),
·
Thermo Fisher Scientific Inc.
·
Among other
Get Full
Access of reports @ https://www.databridgemarketresearch.com/reports/europe-gastric-cancer-diagnostics-market
MAJOR TOC OF THE REPORT
Ø Chapter One: Introduction
Ø Chapter Two: Market Segmentation
Ø Chapter Three: Market Overview
Ø Chapter Four: Executive Summary
Ø Chapter Five: Premium Insights
Ø Chapter Six: Europe Gastric Cancer Diagnostics
Market by Product & Procedure type
Get TOC
Details: https://www.databridgemarketresearch.com/toc/?dbmr=europe-gastric-cancer-diagnostics-market
Browse
Related Reports @
https://www.databridgemarketresearch.com/reports/asia-pacific-pulse-protein-market
https://www.databridgemarketresearch.com/reports/global-transradial-access-market
https://www.databridgemarketresearch.com/reports/north-america-transradial-access-market
https://www.databridgemarketresearch.com/reports/europe-transradial-access-market
https://www.databridgemarketresearch.com/reports/asia-pacific-transradial-access-market
About
Us:-
Data Bridge Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market
Contact:-
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
.webp)
Comments
Post a Comment